Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer
This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.
NALIRIFOX Shows Promise in Early Studies
Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.
Chemotherapy Plus Minimally Invasive Surgery for Pancreatic Cancer
Researchers want to know if irreversible electroporation (IRE), a minimally invasive surgical technique, makes it easier for chemotherapy to reach pancreatic cancer cells.
COMBATing Pancreatic Cancer
Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.
Testing Treatment Combinations to Make Surgery More Effective
Researchers are looking at losartan and nivolumab combined with standard protocol of chemotherapy and radiation to see either drug or a combination is more effective.
I’ll Never Stop Fighting
When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.
My Journey Through Stage IV Pancreatic Cancer
When Chris Parrish was diagnosed with stage IV pancreatic cancer, she searched for a program and a treatment plan until she found a place that gave her hope.
Questions to Ask Before You Begin Chemotherapy
Do you want to better understand your pancreatic cancer treatment? Dr. Andrew Hendifer outlines important questions to ask before starting chemotherapy.
New Study Focuses On Supportive Oncology Care At Home
For some newly diagnosed patients with borderline resectable tumors or locally advanced disease, neoadjuvant therapy is proving to be a…
A New Drug to Target Cancer Cell Enzymes
This trial remains active but is no longer recruiting participants. In patients with metastatic pancreatic cancer, researchers are comparing FOLFIRINOX,…